Syngene International Ltd - 539268 - Reporting Under SEBI (Prevention Of Insider Trading) Regulations, 2015
Please find attached Intimation of Violation under Insider Trading Code by a Designated Employee30-09-2020
30-09-2020
Syngene: Investors with long term view should look at the stock on dips
While Covid-19 could is a near term opportunity, contract manufacturing is the key medium-term trigger24-09-2020
Syngene Int'l hits record high in a weak market, rallies 26% in two weeks
The stock rallied 6.5 per cent to Rs 596.85, surpassing its previous high Rs 594.75, touched on September 15, 2020, on the BSE.24-09-2020
Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Please find attached the schedule of the upcoming Investor Meetings21-09-2020
Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Please find attached the schedule for upcoming investor meeting16-09-2020
Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Please find attached the schedule for upcoming Investor Meetings16-09-2020
Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Please find attached the schedule for upcoming investor meetings14-09-2020
ICMR approves HiMedia-Syngene's Elisa test kit for Covid-19
HiMedia Laboratories, a bioscience company and Syngene International, an integrated R&D services company, have collaborated to manufacture ELISafe10-09-2020
Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find attached the press release tilted ICMR approval for HiMedia-Syngene COVID-19 antibody test kit, ELISafe 19TM'.09-09-2020
Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Please find attached the schedule of the upcoming investor meeting.08-09-2020